Stocks / Apollo Hospitals Enterprise (APOLLOHOSP)

APOLLOHOSP Share Price, Analysis & News

Apollo Hospitals Enterprise (APOLLOHOSP) — Updated on 2026-06-22

Apollo Hospitals Enterprise Limited operates within the healthcare facilities industry, providing integrated services. The company's business model encompasses hospital services and the sale of pharma and wellness products through its pharmacy network. Investors closely monitor Apollo Hospitals Enterprise share price for insights into the company's performance and the broader healthcare sector. Analysis often focuses on the company's financial fundamentals, earnings reports, and prevailing sector trends within healthcare facilities. The integrated nature of its operations, from hospital care to retail pharmacy, forms a key aspect of its market position and investor interest.
Overview Daily Weekly

Key Takeaway

Apollo Hospitals shows strong technical momentum with RSI at 61.66 and robust YoY fundamental growth, supported by predominantly 'Buy' analyst ratings.

Daily

2026-06-22
  • The stock exhibits a strong bullish trend, supported by its price trading above key moving averages and a high RSI of 61.66, indicating robust momentum. This technical strength suggests potential for continued upward movement, despite a slight decline in short-term returns over the last 5 days (-0.035%).
  • Fundamentally, the company has shown impressive growth, with year-over-year revenue increasing by 18.133% and net profit by 33.092% in the latest quarter. This strong performance is reflected in the EPS growth of 35.83%, indicating a healthy expansion in profitability.
  • Analysts maintain a predominantly positive outlook, with 84.6% of ratings being 'Strong Buy' or 'Buy', reflecting confidence in the company's future prospects. This analyst consensus has remained stable, with no significant shifts in recommendations over the past month.
  • Institutional investors hold a substantial 65.38% stake, with a recent reallocation showing DIIs increasing their holdings by 1.26% while FIIs decreased theirs by 0.92%. This suggests a nuanced view among institutional players, with domestic institutions showing increased conviction.
  • The company has recently provided further clarifications on its composite scheme of arrangement, detailing the separate listing of Apollo Healthtech and governance terms. These announcements, made on June 15 and June 19, 2026, aim to provide transparency on the demerger process and its operational aspects.
  • Despite no direct company-specific news impacting price action today, the stock's technical indicators and recent fundamental performance suggest a positive outlook. The price is trading near its 52-week high, indicating strong market interest and potential for further gains if technical and fundamental strengths persist.
Open daily analysis

Weekly

Latest weekly signal
  • The stock price declined by 0.77% this week, closing at 8432.5, amidst a significant 48.63% drop in trading volume.
  • Technical indicators show mixed signals: the price remains above upward-trending moving averages, but RSI is declining and MACD has a bearish crossover.
  • Significant corporate activity centered around the proposed composite scheme of arrangement and the demerger of Apollo Healthtech, with multiple announcements and creditor meetings scheduled.
  • News highlighted the stock reaching 52-week highs and its inclusion in Vanguard's India Portfolio, alongside a proposal for Shobana Kamineni to become Executive Chairperson.
  • The company's recent quarterly performance showed strong growth, with revenue up 18.1% YoY and net profit up 33.1% YoY in the Mar 2026 quarter.
Open weekly analysis

Quarterly

Latest quarterly update
Detailed analysis available on the full page.

Price & Technical Structure

  • Short-term returns show a mixed picture with a slight decline over the last 5 days (-0.035%) but a positive 1-month return of 1.89%.
  • The trend remains bullish with the price above the 50-day and 200-day moving averages, and a trend alignment score of 3.
  • Momentum is strong, indicated by an RSI of 61.66, placing it in the 73.82nd percentile over the past year.
  • Volatility is moderate, with the price positioned at 73.38% of the Bollinger Band width, and an annualized volatility of 15.4%.
  • The stock is trading near its 52-week high, currently at -0.52% distance, with a maximum drawdown of -15.21% over the past year.
The market behaviour indicates a generally bullish trend supported by positive short-term returns and strong momentum. The price is positioned favorably relative to moving averages and Bollinger Bands, suggesting continued upward potential. While the stock is close to its 52-week high, the drawdown history indicates resilience. The volume conviction, though not explicitly detailed with a spike, is noted with accumulation trends.

Weekly Momentum

  • The stock price declined by 0.77% this week, closing at 8432.5, amidst a significant 48.63% drop in trading volume.
  • Technical indicators show mixed signals: the price remains above upward-trending moving averages, but RSI is declining and MACD has a bearish crossover.
  • Significant corporate activity centered around the proposed composite scheme of arrangement and the demerger of Apollo Healthtech, with multiple announcements and creditor meetings scheduled.
  • News highlighted the stock reaching 52-week highs and its inclusion in Vanguard's India Portfolio, alongside a proposal for Shobana Kamineni to become Executive Chairperson.
  • The company's recent quarterly performance showed strong growth, with revenue up 18.1% YoY and net profit up 33.1% YoY in the Mar 2026 quarter.
The stock experienced a minor price dip this week, accompanied by a significant reduction in trading volume, suggesting lower investor interest or a pause in activity. While the price remains above key moving averages, technical indicators like the RSI and MACD signal a potential weakening of bullish momentum. Corporate actions, particularly the ongoing scheme of arrangement and demerger of Apollo Healthtech, continue to be a major focus, alongside positive news regarding stock performance and leadership changes. Recent quarterly results indicate strong underlying business growth.